ANEW Medical Shares Double After European Patent for Klotho Gene Systems

Dow Jones

2024-06-27

By Chris Wack

Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.

The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.

ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.

In March, the company received patent approval in China, and is now approved in Hong Kong as well.

ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

June 26, 2024 13:39 ET (17:39 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2446311876"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2446311876\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2446311876?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-27 01:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446311876","market":"nz","top_or_hot":-1,"title":"ANEW Medical Shares Double After European Patent for Klotho Gene Systems","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n</p>\n<p>\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n</p>\n<p>\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n</p>\n<p>\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n</p>\n<p>\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2024 13:39 ET (17:39 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ANEW Medical Shares Double After European Patent for Klotho Gene Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nANEW Medical Shares Double After European Patent for Klotho Gene Systems\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-06-27 01:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n</p>\n<p>\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n</p>\n<p>\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n</p>\n<p>\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n</p>\n<p>\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2024 13:39 ET (17:39 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANEW","symbol_name":"ProShares MSCI Transformational Changes ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2446311876","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446311876","pubTimestamp":1719423540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.In March, the company received patent approval in China, and is now approved in Hong Kong as well.ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANEW":"ProShares MSCI Transformational Changes ETF","OTS.SI":"OTS Holdings","BK6509":"食品和饮料股","BK6114":"包装食品与肉类"},"translate_title":"Klotho Gene Systems获得欧洲专利后，ANEW Medical股价翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANEW":1,"OTS.SI":1,"WENA":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n\n\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n\n\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n\n\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n\n\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2024 13:39 ET (17:39 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}